---
$id: https://graph.org.ai/products/commodity/51142513
$type: Product
source: UNSPSC
code: "51142513"
title: "Rasagiline"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rasagiline

**UNSPSC Code**: 51142513
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula C12H13N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 003N66TS6T, chemically known as 2,3-dihydro-n-2-propynyl-1h-inden-1-amine but generally known as rasagiline, which bears US NIH Compound Identifier 122316. European Medicines Agency schedules Rasagiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10261MIG. World Health Organization schedules rasagiline in its Anatomical Therapeutic Chemical (ATC) Classification. RASAGILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rasagiline under HS 29214980 and SITC 51454. As of Q4 2014, RASAGILINE remains the US FDA Preferred Term for this commodity. Rasagiline bears US NLM identifiers UMLS ID C0525678 and NCI Concept Code C66510. SMILES: C#CCNC1CCC2=CC=CC=C12.

